Hemophilia is a blood disorder that is almost always inherited, passed from parents to their children through genes. Because it’s a genetic condition someone is born with, there is currently no way to prevent the disease, so scientists are constantly investigating ways that the disease can be stopped before it passes to the next generation.

At the OSUCCC – James, expert researchers continually focus on studying blood diseases and prevention, diagnosis, treatment and cure. In fact, the OSUCCC – James is consistently paving the way in leading-edge therapies and discoveries, leading to even more highly targeted care and treatment.

Couple that with world-renowned diagnostic experts and the most advanced diagnostic techniques to enable physicians to detect hemophilia as early as possible, and patients are experiencing improved outcomes, faster responses to treatment and fewer side effects.

Risk Factors

Anything that increases the chances of having hemophilia is a risk factor. Because it is almost always an inherited disorder, it is handed down through parents’ genes.

It’s important to note that some people have the genes for hemophilia but don't have symptoms. Even without symptoms, however, it’s still possible to pass the genes on to your children.

For patients with a family history of hemophilia, the OSUCCC – James offers genetic counseling at the Clinical Cancer Genetics Program.

 

If you’ve been diagnosed with hemophilia, would like a second opinion or would like to speak with a blood disorder specialist, please call The James Line at 800-293-5066 or 614-293-5066 to make an appointment.

Make an Appointment

800-293-5066

Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator

OR

Please enter a keyword (i.e. Name, Location) or choose a Cancer Type

OR

Patient Story

Patient Stories Ken Mcnutt

Mark Sulzman

Born with severe hemophilia, Mark Sulzman sought out benign hematology experts at OSUCCC – James to help him manage the disorder with the most advanced treatments.

Read More